- Home
- FGEN vs ORKT Comparison
FGEN vs ORKT Comparison
Compare FGEN & ORKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- ORKT
- Stock Information
- Founded
- FGEN 1993
- ORKT 2003
- Country
- FGEN United States
- ORKT Singapore
- Employees
- FGEN N/A
- ORKT N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- ORKT
- Sector
- FGEN Health Care
- ORKT
- Exchange
- FGEN Nasdaq
- ORKT NYSE
- Market Cap
- FGEN 33.5M
- ORKT N/A
- IPO Year
- FGEN 2014
- ORKT 2024
- Fundamental
- Price
- FGEN $5.61
- ORKT $0.58
- Analyst Decision
- FGEN Strong Buy
- ORKT Strong Buy
- Analyst Count
- FGEN 1
- ORKT 1
- Target Price
- FGEN $250.00
- ORKT $5.00
- AVG Volume (30 Days)
- FGEN 60.2K
- ORKT 266.3K
- Earning Date
- FGEN 08-05-2025
- ORKT 01-01-0001
- Dividend Yield
- FGEN N/A
- ORKT N/A
- EPS Growth
- FGEN N/A
- ORKT N/A
- EPS
- FGEN N/A
- ORKT N/A
- Revenue
- FGEN $6,996,000.00
- ORKT $2,962,282.00
- Revenue This Year
- FGEN N/A
- ORKT $9.63
- Revenue Next Year
- FGEN N/A
- ORKT N/A
- P/E Ratio
- FGEN N/A
- ORKT N/A
- Revenue Growth
- FGEN N/A
- ORKT N/A
- 52 Week Low
- FGEN $4.50
- ORKT $0.40
- 52 Week High
- FGEN $38.25
- ORKT $8.00
- Technical
- Relative Strength Index (RSI)
- FGEN 39.07
- ORKT N/A
- Support Level
- FGEN $4.85
- ORKT N/A
- Resistance Level
- FGEN $5.77
- ORKT N/A
- Average True Range (ATR)
- FGEN 0.57
- ORKT 0.00
- MACD
- FGEN -0.02
- ORKT 0.00
- Stochastic Oscillator
- FGEN 31.67
- ORKT 0.00
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.